Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion type Assertion NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_head.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion description "[Men carrying an MSH2 mutation and their first degree relatives were at highest risks: CR70 for bladder and upper urinary tract cancer being 12.3% (95% CI 4.3% to 20.3%) and 5.9% (95% CI 0.7% to 11.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_provenance.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion evidence source_evidence_literature NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_provenance.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion SIO_000772 20591884 NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_provenance.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion wasDerivedFrom befree-20140225 NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_provenance.
- NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_assertion wasGeneratedBy ECO_0000203 NP387474.RAsoToADTU50NmyeVyTllMYxkJDcwinLqlJG1jdX8I_oY130_provenance.